Studies investigating changes in relation to dementia risk factors have so far focussed on older participants (mean ages in the eighth decade of life) and on markers of heritable risk such as APOE4 status or established AD biomarkers (e.g. positive amyloid PET) rather than potentially modifiable risk factors such as those related to cardiovascular risk. This evidence concerns the gene APOE and Alzheimer disease.